Keeping up with type 1 diabetes technology changes in primary care ...
Keeping up with type 1 diabetes technology changes in primary care ...
Keeping up with type 1 diabetes technology changes in primary care ...
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up. The US Food and Drug Administration (FDA) has ...
The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors. The FDA has approved concizumab-mtci (Alhemo; Novo Nordisk) in ...
Keeping up with type 1 diabetes technology changes in primary care ...
The expanded indication is approved to reduce excess body weight and maintain reduction long-term in children 2 years and up with obesity due to BBS, POMC, or LEPR deficiency. The FDA has approved an ...
Positive phase 3 data for inhaled insulin Afrezza Inhalation Powder (MannKind Corporation) in children and adolescents aged 4 to 17 years has been announced by MannKind Corporation. 1 According to the ...
"Tapinarof comes in with that mixture of the short-term studies and longer-term studies intermittently, giving us a nice, effective alternative non-steroid for eczema across the ages." Lawrence ...
The article by Colleen Sloan, PA-C, RDN, Healthy eyes in a digital world, provides detailed information about the relationship between nutrition and screen time for young children. Sloan presents the ...